Show simple item record

dc.contributor.advisorRichard O. Hynes.en_US
dc.contributor.authorFrew, Sarah Elizabeth Ann, 1976-en_US
dc.contributor.otherMassachusetts Institute of Technology. Dept. of Biology.en_US
dc.date.accessioned2005-09-06T21:27:42Z
dc.date.available2005-09-06T21:27:42Z
dc.date.copyright2004en_US
dc.date.issued2004en_US
dc.identifier.urihttp://hdl.handle.net/1721.1/27045
dc.descriptionThesis (Ph. D.)--Massachusetts Institute of Technology, Dept. of Biology, 2004.en_US
dc.descriptionIncludes bibliographical references (leaves 108-124).en_US
dc.description.abstractMetastasis, or the spread of a primary tumor to distal sites in the body, is the major cause of human cancer-related morbidity and mortality. Metastasis requires a complex series of cellular events that remain poorly understood at the molecular level. Recently, advances in microarray technology have allowed cancer biologists to globally survey metastatic progression and define patterns of gene expression that correlate with progression to a metastatic phenotype. By using such a genomic approach, our laboratory identified a subset of genes that regulate the actin cytoskeleton whose enhanced expression correlates with metastasis. This thesis describes the characterization of IQGAP1, a key regulator of the cytoskeleton, as a potentially critical player in metastatic progression. Here I show a strong positive correlation between IQGAP1 expression levels and metastatic progression in both in vivo-selected human metastatic melanoma cells and other human tumors. In addition, I have experimentally analyzed the role of IQGAP1 in metastasis using two different dominant-negative mutants. The results suggest that IQGAP1 may play a functional role in metastatic progression, particularly in the processes of cell migration and invasion. This work lays a scientific framework by which cancer biologists can look at global gene expression analyses and then probe deeper into individual genes to define the molecular mechanisms underlying their roles. In addition, this work contributes to a deeper understanding of the molecular pathogenesis of metastasis, and identifies in IQGAP 1 a potential molecular target for future tumor metastasis therapies.en_US
dc.description.statementofresponsibilityby Sarah Elizabeth Ann Frew.en_US
dc.format.extent124 leavesen_US
dc.format.extent7626998 bytes
dc.format.extent7642227 bytes
dc.format.mimetypeapplication/pdf
dc.format.mimetypeapplication/pdf
dc.language.isoen_US
dc.publisherMassachusetts Institute of Technologyen_US
dc.rightsM.I.T. theses are protected by copyright. They may be viewed from this source for any purpose, but reproduction or distribution in any format is prohibited without written permission. See provided URL for inquiries about permission.en_US
dc.rights.urihttp://dspace.mit.edu/handle/1721.1/7582
dc.subjectBiology.en_US
dc.titleInvestigation of the role of IQGAP1 in metastasisen_US
dc.typeThesisen_US
dc.description.degreePh.D.en_US
dc.contributor.departmentMassachusetts Institute of Technology. Department of Biology
dc.identifier.oclc56795014en_US


Files in this item

Thumbnail

This item appears in the following Collection(s)

Show simple item record